Approach: Developing a highly-sensitive glucose-responsive insulin
Strategic Area: Improving Lives
T1D Funding Impact: Accelerating the development of a novel insulin formulation
Member count: 11-50
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | T1D Fund | t1dfund.or... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 14.07.2021 | Eli Lilly ... | Eli Lilly, already a leader in... | - | - | medcitynew... |
| 14.07.2021 | Big Pharma... | Two Southern California biotec... | biotech | Keerth... | dot.la/los... |
| 09.11.2020 | Protomer G... | Protomer Technologies Inc., a ... | biotech in... | France... | dot.la/glu... |
| 09.11.2020 | Pasadena B... | Protomer Technologies Inc., a ... | biotech in... | France... | dot.la/glu... |
| 05.11.2020 | Protom... | Pasadena-based Protomer Techno... | - | - | socaltech.... |
| - | Eli Lilly ... | Eli Lilly, already a leader in... | - | - | medcitynew... |